Skip to main content

Table1 Correlation of the expression of FEZF1-AS1 with clinicopathologic features in gastric cancer

From: LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation

Characteristics

N (%)

FEZF1-AS1 a

p-value

  

High

Low

 

Gender

   

0.528

 Male

51(62.20%)

31

20

 

 Female

31(37.80%)

21

10

 

Age

   

0.670

 ≤65

27(32.93%)

18

9

 

 >65

55(67.07%)

34

21

 

Stage

   

0.023*

 I

9(10.97%)

5

4

 

 II

23(28.05%)

10

13

 

 III

50(60.98%)

37

13

 

Tumor size

   

0.010*

 ≤5

29(35.37%)

13

16

 

 >5

53(64.63%)

39

14

 

Defferation

   

0.482

 Well

37(45.12%)

25

12

 

 Poorly

45(54.88%)

27

18

 

Lauren type

    

 Intestinal

35(42.68%)

20

15

0.312

 Diffuse

47(57.32%)

32

15

 
  1. aFold change(FC) (tumor tissues relative to normal tissues) Fold change is greater than or equal to 2.0 for high expression, and less than 2.0 for low expression
  2. *P < 0.05 was considered significant (Mann–Whitney U test between 2 groups,Kruskal-Wallis H(K) test among 3 groups)
Back to article page

Molecular Cancer

ISSN: 1476-4598